Background and Objectives: Pilocarpine is used in experimental studies for testing antiepileptic drugs, but further characterization of this model is essential for its usage in testing novel drugs. The aim of our study was to study the behavioral and EEG
Dolika Vasović +7 more
doaj +1 more source
Background Pilocarpine HCl is a non-selective muscarinic receptor agonist that is prescribed for the treatment of glaucoma. The use of pilocarpine conventional eye drops is associated with several side effects, such as loss of visual acuity, and the need
Tamara Ahmad Alotaibi +3 more
doaj +1 more source
Objective: This study aimed to assess and compare the effectiveness and side effects of various concentrations of pilocarpine eye drops (1.5%, 1.25%, and 1%), with and without 0.1% brimonidine, in treating presbyopia, specifically in a Thai population.
Thammanoon Surachatkumtonekul +6 more
doaj
Temporal lobe epilepsy and changes in the M current
Objective: Acquired alterations of ion channel function occur after status epilepticus (SE). Kv7 channels mediate a sustained outward current (IM) that exerts pivotal control over neuronal excitability.
Hugo Solís, Estela López-Hernández
doaj
Efficacy and safety of pilocarpine as a secretagogue versus artificial tears in the management of dry eye disease. [PDF]
Elsayed Saad EM +9 more
europepmc +1 more source
From molecular design to antiepileptic evaluation: sulfonamide-pyrazole derivatives as promising neuroactive agents. [PDF]
Elgohary MK +9 more
europepmc +1 more source
Enhancing presbyopia treatment: A comparative study of 1% Pilocarpine monotherapy versus combination with 0.09% Bromfenac. [PDF]
Jain A +5 more
europepmc +1 more source
Author's response Comments on: Efficacy and safety of pilocarpine hydrochloride ophthalmic solution USP 1.25% w/v (PresVu eye drops) versus placebo ophthalmic solution for the treatment of presbyopia - A multicentric clinical trial. [PDF]
Singh P +5 more
europepmc +1 more source
Effects of an orexin receptor 2-selective agonist on salivary secretion in rats. [PDF]
Ichishima J, Nakakariya M, Kimura H.
europepmc +1 more source

